Iovance Biotherapeutics Affirms FY2026 Sales Guidance of $410.000M-$420.000M vs $416.263M Est
Benzinga Newsdesk 2 hours ago
NewsGuidance
Iovance Biotherapeutics (NASDAQ:IOVA) affirms FY2026 sales outlook from $410.000 million-$420.000 million to $410.000 million-$420.000 million vs $416.263 million estimate.
Iovance Biotherapeutics (NASDAQ:IOVA) affirms FY2026 sales outlook from $410.000 million-$420.000 million to $410.000 million-$420.000 million vs $416.263 million estimate.